![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Oklahoma Judge Reduces J&J Opioid Order by $107 Million
Oklahoma Judge Reduces J&J Opioid Order by $107 Million
December 2, 2019
An Oklahoma judge reduced by $107 million the amount Johnson & Johnson must pay for its role in the state’s opioid crisis following a “miscalculation.”
District Judge Thad Balkman admitted that he miscalculated how much it would cost to develop a program for babies born addicted to opioids. The program, which he originally understood would cost $107 million, would instead cost an estimated $107,000.
Balkman originally ordered J&J and its subsidiary Janssen to pay $572 million to the state for its role in the opioid epidemic. J&J will now pay $465 million.
Upcoming Events
-
21Oct